COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
Vitamin D study #33 of 69
10/31 Late treatment study
Ohaegbulam et al., American Journal of Therapeutics, doi:10.1097/MJT.0000000000001222 (Peer Reviewed)
Vitamin D Supplementation in COVID-19 Patients: A Clinical Case Series
Source   PDF   Share   Tweet
Small case study of 4 vitamin D deficient patients with 2 patients treated with cholecalciferol 1000 IU daily and two patients treated with ergocalciferol 50,000 IU daily for 5 days (high dose), showing that patients receiving high dose therapy had improved clinical recovery, with shorter lengths of stay, lower oxygen requirements, and a reduction in inflammatory marker status.

Ohaegbulam et al., 10/31/2020, peer-reviewed, 5 authors.
Details of all 69 studies
Please send us corrections, updates, or comments.
Submit